Published Date: 08 Mar 2023
While researchers have successfully detected symptoms of Alzheimer's disease using brain tests collected through their research, a team from the Massachusetts General Hospital Mob (MGH) recently...
Read Full NewsAbout one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.
A ‘target trial’ emulation study suggests that regular exercise can help breast cancer survivors live longer.
Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region could affect diagnosis and care of much more than just this cancer.
Counterintuitive findings hint that diets rich in fruit, vegetables, and whole grains may increase the risk of lung cancer in young nonsmokers, but experts are skeptical.
Photopenia in high CT density renal lesions on [18F]FDG PET/CT scans shows a high negative predictive value for excluding malignancy.
A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.
Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.
1.
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
2.
Surgeons are at higher risk of cancer, study suggests
3.
What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?
4.
Cancer care crowdfunding increasingly common, but rarely successful
5.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
3.
Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study
4.
Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies
5.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation